These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y. Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193 [TBL] [Abstract][Full Text] [Related]
3. The role of neuropeptide Y in cardiovascular regulation. Walker P; Grouzmann E; Burnier M; Waeber B Trends Pharmacol Sci; 1991 Mar; 12(3):111-5. PubMed ID: 2053188 [TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y: a possible role in hypertension? Michel MC; Rascher W J Hypertens; 1995 Apr; 13(4):385-95. PubMed ID: 7629398 [TBL] [Abstract][Full Text] [Related]
5. Localisation of neuropeptide Y in nerves of the rat cardiovascular system and the effect of 6-hydroxydopamine. Allen JM; Polak JM; Rodrigo J; Darcy K; Bloom SR Cardiovasc Res; 1985 Sep; 19(9):570-7. PubMed ID: 3930070 [TBL] [Abstract][Full Text] [Related]
6. Distribution and activity of dogfish NPY and peptide YY in the cardiovascular system of the common dogfish. Bjenning C; Hazon N; Balasubramaniam A; Holmgren S; Conlon JM Am J Physiol; 1993 Jun; 264(6 Pt 2):R1119-24. PubMed ID: 8322964 [TBL] [Abstract][Full Text] [Related]
7. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers. Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156 [TBL] [Abstract][Full Text] [Related]
8. Actions of neuropeptide Y on the rat adrenal cortex. Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor. Zukowska-Grojec Z Adv Pharmacol; 1998; 42():125-8. PubMed ID: 9327862 [No Abstract] [Full Text] [Related]
10. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Zukowska Z; Pons J; Lee EW; Li L Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520 [TBL] [Abstract][Full Text] [Related]
11. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide. Modin A Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Zukowska-Grojec Z; Shen GH; Capraro PA; Vaz CA Physiol Behav; 1991 Apr; 49(4):771-7. PubMed ID: 1881983 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat. Pham TM; de Champlain J; Couture R Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):42-9. PubMed ID: 8446182 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying changes in the contents of neuropeptide Y in cardiovascular nerves and adrenal gland induced by sympatholytic drugs. Lundberg JM; Saria A; Franco-Cereceda A; Theodorsson-Norheim E Acta Physiol Scand; 1985 Aug; 124(4):603-11. PubMed ID: 3840321 [TBL] [Abstract][Full Text] [Related]